Clinical Trial Update: Study Evaluating Toxicity & Efficacy of Lenalidomide(Revlimid®)in Chemotherapy-Naïve AIPC Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating toxicity and efficacy of lenalidomide (Revlimid) in chemotherapy-naïve androgen-independent prostate cancer patients; study co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Revlimid (lenalidomide)

Snippet

Sponsor: Oncology Specialists, S.C. | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2014-02-28